Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017902 |
---|---|
Receipt number | R000020386 |
Scientific Title | Phase I clinical trial of preoperative arterial immuno-embolization with OK-432 / fibrinogen / lipiodol for resectable primary hepatocellular carcinoma |
Date of disclosure of the study information | 2015/06/15 |
Last modified on | 2019/11/06 18:46:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/06/14 18:39:13 | ||
2 | Update | 2016/06/14 13:57:27 | Name of primary person or sponsor Organization Organization |
|
3 | Update | 2016/12/19 11:24:30 | Interventions/Control_1 |
|
4 | Update | 2017/06/14 15:24:13 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name TEL Division name Division name TEL Division name Division name TEL Institute Institute Co-sponsor Co-sponsor |
|
5 | Update | 2017/06/14 15:25:41 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2019/06/17 09:19:49 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
7 | Update | 2019/06/17 09:25:08 | Date of IRB |
|
8 | Update | 2019/06/17 09:25:50 | Recruitment status |
|
9 | Update | 2019/11/06 18:46:50 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |